Detalles de la búsqueda
1.
Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40L Linkage.
Am J Pathol
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38548267
2.
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy.
Hepatol Res
; 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323994
3.
Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus-Sustained Virological Response Patients.
Am J Pathol
; 192(10): 1379-1396, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963463
4.
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
J Viral Hepat
; 30(5): 374-385, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36583600
5.
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.
J Viral Hepat
; 29(1): 52-59, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695288
6.
Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation.
J Med Virol
; 93(6): 3679-3687, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940921
7.
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas.
Oncology
; 99(3): 186-191, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33032274
8.
Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinoma.
Hepatol Res
; 51(11): 1102-1114, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476874
9.
Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure.
Hepatol Res
; 51(5): 593-602, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33677839
10.
Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C.
J Gastroenterol Hepatol
; 36(1): 217-224, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453907
11.
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
Ann Hepatol
; 19(4): 367-372, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444247
12.
Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.
Int J Mol Sci
; 21(12)2020 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32630450
13.
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
J Gastroenterol Hepatol
; 34(5): 937-946, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30160782
14.
Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B.
Hepatol Res
; 48(6): 459-468, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29314465
15.
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy.
J Gastroenterol Hepatol
; 32(8): 1495-1502, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109022
16.
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.
Ann Hepatol
; 16(5): 734-741, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28809743
17.
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed.
Int J Mol Sci
; 18(5)2017 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467359
18.
Production of insulin-like growth factor-II in hepatocellular carcinoma with recurrent hypoglycemia: a case report.
Nihon Shokakibyo Gakkai Zasshi
; 114(2): 256-263, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-28163291
19.
Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein.
Gut
; 70(6): 1199-1201, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816966
20.
Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
Am J Gastroenterol
; 116(4): 631, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982923